| scholarly article | Q13442814 |
| P2093 | author name string | D Pei | |
| W Yang | |||
| N J Cox | |||
| M V Relling | |||
| W E Evans | |||
| C Cheng | |||
| C-H Pui | |||
| S Jeha | |||
| S-H Chen | |||
| P2860 | cites work | Inference of population structure using multilocus genotype data | Q24548114 |
| Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence | Q24563210 | ||
| Treating childhood acute lymphoblastic leukemia without cranial irradiation | Q24644599 | ||
| Comprehensive testing of positionally cloned asthma genes in two populations | Q24670496 | ||
| Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations | Q28210684 | ||
| Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia | Q28943308 | ||
| Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis | Q28943498 | ||
| Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group | Q33903257 | ||
| Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma | Q34020832 | ||
| Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder | Q34033559 | ||
| Immunological responses to L-asparaginase | Q34060926 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| l-Asparaginase resistance in human leukemia—Asparagine synthetase | Q34223773 | ||
| Heterogeneity of childhood asthma among Hispanic children: Puerto Rican children bear a disproportionate burden | Q34482142 | ||
| Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster | Q34502235 | ||
| HLA-B*5701 screening for hypersensitivity to abacavir | Q34747145 | ||
| Gene polymorphisms within the immune system that may underlie drug allergy | Q35552886 | ||
| A genomewide admixture mapping panel for Hispanic/Latino populations. | Q35788553 | ||
| Genetic aspects of immune-mediated adverse drug effects | Q36028231 | ||
| Treatment of acute lymphoblastic leukemia | Q36366185 | ||
| New therapeutic strategies for the treatment of acute lymphoblastic leukaemia | Q36724661 | ||
| Role of glutamate on T-cell mediated immunity. | Q36736561 | ||
| The emergence of neurotransmitters as immune modulators. | Q36906159 | ||
| High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients | Q37150304 | ||
| Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant | Q37356747 | ||
| Racial disparities in childhood asthma in the United States: evidence from the National Health Interview Survey, 1997 to 2003. | Q39753610 | ||
| Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia | Q40639781 | ||
| Favorable remission induction rate with twice weekly doses of L-asparaginase | Q40914662 | ||
| Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia | Q40925974 | ||
| Toxicity of E. coli L-asparaginase in man | Q40934608 | ||
| Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma | Q43606071 | ||
| Therapy of acute leukemia with drug combinations which include asparaginase | Q44685791 | ||
| Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations | Q44796890 | ||
| Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics | Q46129563 | ||
| Genetic influences of chromosomes 5q31-q33 and 11q13 on specific IgE responsiveness to common inhaled allergens among African American families. Collaborative Study on the Genetics of Asthma (CSGA). | Q46663212 | ||
| Asthma prevalence among US children in underrepresented minority populations: American Indian/Alaska Native, Chinese, Filipino, and Asian Indian | Q46677406 | ||
| Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample | Q46982053 | ||
| Toxicity of L-asparaginase in children with advanced leukemia | Q54421324 | ||
| Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. | Q54434907 | ||
| Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. | Q54786383 | ||
| Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia | Q66849976 | ||
| L-asparaginase in the treatment of neoplastic diseases in children | Q68627750 | ||
| Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma | Q70218193 | ||
| Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia | Q71045983 | ||
| Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases | Q71083416 | ||
| Comparative pharmacokinetic studies of three asparaginase preparations | Q72888578 | ||
| Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers | Q73167589 | ||
| Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia | Q73589836 | ||
| Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population | Q73885838 | ||
| Genome-wide search for atopy susceptibility genes in Dutch families with asthma | Q77773997 | ||
| A genome-wide search for allergic response (atopy) genes in three ethnic groups: Collaborative Study on the Genetics of Asthma | Q79228057 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 191-196 | |
| P577 | publication date | 2010-06-30 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity | |
| P478 | volume | 88 |
| Q39459190 | Advances in adult acute lymphoblastic leukemia therapy |
| Q92682837 | Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge |
| Q34077747 | Asparaginase allergies: it's all in the genes |
| Q36452241 | Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia |
| Q35776973 | Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia |
| Q38933372 | Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia |
| Q41491082 | Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study |
| Q37385443 | Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. |
| Q28271185 | Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review |
| Q36143232 | Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia |
| Q35820373 | Genome-wide analysis links NFATC2 with asparaginase hypersensitivity |
| Q35565624 | Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease |
| Q64102700 | Genome-wide association study of endo-parasite phenotypes using imputed whole-genome sequence data in dairy and beef cattle |
| Q30371340 | HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. |
| Q38735393 | HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia |
| Q27026952 | How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia |
| Q38880102 | Immunology of infusion reactions in the treatment of patients with acute lymphoblastic leukemia |
| Q38063197 | Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia |
| Q35784497 | Inherited genetic variation in childhood acute lymphoblastic leukemia |
| Q38079075 | Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults |
| Q33557148 | Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. |
| Q64269386 | Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity |
| Q38895172 | Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia |
| Q38199738 | Pharmacogenetic considerations for acute lymphoblastic leukemia therapies |
| Q38243175 | Pharmacogenetics of childhood acute lymphoblastic leukemia. |
| Q28083449 | Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy |
| Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
| Q64077129 | Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment |
| Q34707586 | Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia |
| Q45261834 | Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia |
| Q34644733 | Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia. |
| Q92542001 | Precision Medicine in Lymphoma by Innovative Instrumental Platforms |
| Q28083100 | Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity |
| Q35803355 | Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity |
| Q33632120 | The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment. |
| Q27003261 | Using germline genomics to individualize pediatric cancer treatments |
| Q38748699 | Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients |
Search more.